MediPoint: Enteral Stents-Europe Forecast and Market Analysis

MediPoint: Enteral Stents-Europe Forecast and Market Analysis


  • Products Id :- GDME1321CFR
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

MediPoint: Enteral Stents-Europe Forecast and Market Analysis

Summary

Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent. The market is led by three key players. The market will continue to grow as cancer prevalence increases and patients become more familiar with enteral stenting as a treatment option. This report examines the enteral stents market in 21 major European markets: Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey and the UK.

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the European market.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Executive Summary 5

2.1 Overview 5

2.2 Market Dynamics 6

2.3 Key Players 7

2.4 Future Outlook 7

3 Introduction 8

3.1 Catalyst 8

3.2 Related Reports 8

3.3 Upcoming Related Reports 8

4 Market Outlook 9

4.1 Procedure Trends 9

4.2 Pricing Trends 13

4.3 Revenue Trends 16

4.4 Company Share Analysis 19

5 Market Insights 20

5.1 Europe 20

5.1.1 Denmark, Finland, Norway, and Sweden 20

5.1.2 Belgium, France, and Netherlands 20

5.1.3 Austria, Germany, and Switzerland 21

5.1.4 UK and Ireland 21

5.1.5 Italy, Portugal, and Spain 21

5.1.6 Czech Republic, Hungary, and Poland 22

5.1.7 Russia, Turkey, and Greece 22

6 Competitive Assessment 23

6.1 Boston Scientific 23

6.1.1 Overview 23

6.1.2 Portfolio Assessment 23

6.1.3 Deal Analysis 23

6.1.4 Competitive Positioning 24

6.2 Cook Medical 24

6.2.1 Overview 24

6.2.2 Portfolio Assessment 24

6.2.3 Competitive Positioning 24

6.3 Taewoong Medical 25

6.3.1 Overview 25

6.3.2 Portfolio Assessment 25

6.3.3 Competitive Positioning 25

6.4 Other Players 26

7 Appendix 27

7.1 Bibliography 27

7.2 Abbreviations 28

7.3 Methodology 29

7.3.1 Overview 29

7.3.2 Coverage 29

7.3.3 Secondary Research 29

7.3.4 Forecasting Methodology 30

7.3.5 Primary Research Summary 31

7.4 About the Authors 32

7.4.1 Analysts 32

7.4.2 Global Head of Medical Devices 32

7.5 About MediPoint 33

7.6 About GlobalData 33

7.7 Contact Us 33

7.8 Disclaimer 34

1.2 List of Figures

Figure 1: Enteral Stents Sales for Europe, by Country, 2016 and 2023 6

1.1 List of Tables

Table 1: Key Metrics in the Europe Enteral Stents Market 5

Table 2: Europe Enteral Stenting Procedure Volume Forecast, 2014-2023 9

Table 3: Europe Enteral Stents Average Selling Price ($) Forecast, 2014-2023 13

Table 4: Europe Enteral Stents Sales Forecast ($M), 2014-2023 16

Table 5: Europe Company Share Analysis, 2016 19

Table 6: Product Portfolio-Boston Scientific 23

Table 7: Product Portfolio-Cook Medical 24

Table 8: Product Portfolio -Taewoong Medical 25

Table 9: Other Players Assessment 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Boston Scientific, Cook Medical, Taewoong Medical

select a license
Single User License
USD 5000 INR 350000
Site License
USD 10000 INR 700000
Corporate User License
USD 15000 INR 1050000

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com